Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer
2024; Massachusetts Medical Society; Volume: 391; Issue: 15 Linguagem: Inglês
10.1056/nejmoa2403365
ISSN1533-4406
AutoresNicholas van As, Clare Griffin, Alison Tree, Jaymini Patel, Peter Ostler, H. van der Voet, Andrew Loblaw, William Chu, Daniel Ford, Shaun Tolan, Suneil Jain, Philip Camilleri, Kiran Kancherla, J. Frew, Andrew K. Chan, Olivia Naismith, John Armstrong, John Staffurth, Alexander Martin, Ian S. Dayes, Paula Wells, Derek Price, Emily Williamson, Julia Pugh, Georgina Manning, Stephanie Brown, Stephanie Burnett, Emma Hall,
Tópico(s)Advanced Radiotherapy Techniques
ResumoWhether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or moderately hypofractionated regimens with respect to biochemical or clinical failure in patients with localized prostate cancer is unclear.
Referência(s)